Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | REGISTRATION STATEMENT | fs12022_cadrenal.htm | S-1 | 3377236 |
| 2 | CERTIFICATE OF INCORPORATION FILED WITH THE SECRETARY OF STATE OF DELAWARE ON JA | fs12022ex3-1_cadrenal.htm | EX-3.1 | 6128 |
| 3 | BYLAWS | fs12022ex3-2_cadrenal.htm | EX-3.2 | 64433 |
| 4 | FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION | fs12022ex3-3_cadrenal.htm | EX-3.3 | 27744 |
| 5 | FORM OF AMENDED AND RESTATED BYLAWS | fs12022ex3-4_cadrenal.htm | EX-3.4 | 172220 |
| 6 | CONVERTIBLE PROMISSORY NOTE DATED MARCH 1, 2022 ISSUED TO JOHN MURPHY | fs12022ex4-3_cadrenal.htm | EX-4.3 | 35350 |
| 7 | FORM OF CONVERTIBLE NOTE DATED JUNE 13, 2022 | fs12022ex4-4_cadrenal.htm | EX-4.4 | 26303 |
| 8 | FORM OF PRIVATE PLACEMENT CONVERTIBLE NOTE | fs12022ex4-5_cadrenal.htm | EX-4.5 | 71459 |
| 9 | FORM OF PLACEMENT AGENT WARRANT | fs12022ex4-6_cadrenal.htm | EX-4.6 | 116022 |
| 10 | CADRENAL THERAPEUTICS, INC. 2022 EQUITY INCENTIVE PLAN AND FORM OF INCENTIVE STO | fs12022ex10-1_cadrenal.htm | EX-10.1 | 289309 |
| 11 | CONSULTING AGREEMENT, DATED JANUARY 25, 2022, WITH PHAMACE LLC (QUANG PHAM) FROM | fs12022ex10-2_cadrenal.htm | EX-10.2 | 21912 |
| 12 | EMPLOYMENT AGREEMENT, DATED MARCH 1, 2022 WITH QUANG PHAM | fs12022ex10-3_cadrenal.htm | EX-10.3 | 86230 |
| 13 | CONSULTING AGREEMENT, DATED MAY 17, 2022, WITH MATTHEW SZOT | fs12022ex10-4_cadrenal.htm | EX-10.4 | 74833 |
| 14 | RESTRICTED STOCK PURCHASE AGREEMENT WITH MATTHEW SZOT | fs12022ex10-5_cadrenal.htm | EX-10.5 | 35085 |
| 15 | FORM OF EMPLOYMENT AGREEMENT TO BE ENTERED INTO WITH MATTHEW SZOT | fs12022ex10-6_cadrenal.htm | EX-10.6 | 151964 |
| 16 | ASSET PURCHASE AGREEMENT DATED AS OF APRIL 1, 2022, BETWEEN CADRENAL THERAPEUTIC | fs12022ex10-7_cadrenal.htm | EX-10.7 | 243788 |
| 17 | PATENT ASSIGNMENT AGREEMENT DATED AS OF APRIL 1, 2022, BETWEEN CADRENAL THERAPEU | fs12022ex10-8_cadrenal.htm | EX-10.8 | 63871 |
| 18 | SUBSCRIPTION AGREEMENT WITH QUANG PHAM, DATED JANUARY 25, 2022 | fs12022ex10-9_cadrenal.htm | EX-10.9 | 59507 |
| 19 | FORM OF INVESTOR RIGHTS AND LOCKUP AGREEMENT | fs12022ex10-10_cadrenal.htm | EX-10.10 | 68767 |
| 20 | AMENDMENT TO ASSET PURCHASE AGREEMENT, DATED AS OF AUGUST 18, 2022, BETWEEN CADR | fs12022ex10-11_cadrenal.htm | EX-10.11 | 21701 |
| 21 | FORM OF EMPLOYMENT AGREEMENT TO BE ENTERED INTO WITH DOUGLAS LOSORDO | fs12022ex10-12_cadrenal.htm | EX-10.12 | 142447 |
| 22 | LIST OF SUBSIDIARIES OF THE REGISTRANT | fs12022ex21-1_cadrenal.htm | EX-21.1 | 1080 |
| 23 | CONSENT OF WITHUMSMITH + BROWN, PC, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIR | fs12022ex23-1_cadrenal.htm | EX-23.1 | 1936 |
| 24 | CONSENT OF DIRECTOR NOMINEE (JOHN R. MURPHY) | fs12022ex99-1_cadrenal.htm | EX-99.1 | 2456 |
| 25 | CONSENT OF DIRECTOR NOMINEE (STEVEN ZELENKOFSKE) | fs12022ex99-2_cadrenal.htm | EX-99.2 | 2506 |
| 26 | CONSENT OF DIRECTOR NOMINEE (GLYNN WILSON) | fs12022ex99-3_cadrenal.htm | EX-99.3 | 2443 |
| 27 | CALCULATION OF FILING FEE TABLES | fs12022ex-fee_cadrenal.htm | EX-FILING FEES | 27168 |
| 28 | GRAPHIC | tlogo_001.jpg | GRAPHIC | 63038 |
| 29 | GRAPHIC | tlinechart_001.jpg | GRAPHIC | 173429 |
| 30 | GRAPHIC | tflowchart_001.jpg | GRAPHIC | 213203 |
| 31 | GRAPHIC | tlinechart_002.jpg | GRAPHIC | 232289 |
| 32 | GRAPHIC | tlinechart_003.jpg | GRAPHIC | 155964 |
| 33 | GRAPHIC | tbarchart_001.jpg | GRAPHIC | 184805 |
| 34 | GRAPHIC | tbarchart_002.jpg | GRAPHIC | 213188 |
| 35 | GRAPHIC | tflowchart_002.jpg | GRAPHIC | 167409 |
| 36 | GRAPHIC | tlogo_0011.jpg | GRAPHIC | 63049 |
| Complete submission text file | 0001213900-22-058071.txt | 7215804 |
IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-267562 | Film No.: 221260131
SIC: 2834 Pharmaceutical Preparations
